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ABSTRACT
Cardiovascular involvement of amyloidosis is present in 90% of cases, which is frequently associated with the primary form 
of the disease (AL amyloidosis). Clinical manifestations are represented by heart failure due to restrictive myocardiopathy 
and electrical impulse conduction abnormalities, which are clinically remarkable in up to 50% of the cases. The prognosis 
of patients with systemic amyloidosis is directly associated with the presence of cardiac involvement, such that survival 
does not usually exceed 4 months after the onset of heart failure signs and symptoms. The authors report a case of 
primary systemic amyloidosis, diagnosed only at autopsy, with severe cardiac involvement.
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INTRODUCTION
Amyloidosis comprises a group of disorders 
that share, in common, the interstitial deposition of 
insoluble fibril protein, called amyloid, which exhibits 
particular physicochemical and staining properties. This 
substance may be identified by different histochemical 
methods such as the Congo red dye that produces an 
apple-green birefringence on stained sections under 
polarized light.
The amyloid deposition may be organ-specific 
or multisystemic. Infiltrated tissue exhibits damaged 
function by compression and atrophy of the interstitial 
cells. Cardiac amyloidosis is the most common 
infiltrative cardiomyopathy.1
Two types of amyloid commonly infiltrate the heart: 
a) immunoglobulin light-chain (AL or primary systemic) 
amyloid, and b) transthyretin (TTR) amyloid.2 Cardiac 
involvement in amyloidosis is commonly associated 
with the primary form of the disease (AL amyloidosis), 
which is related to the deposition of monoclonal light 
chain immunoglobulin.3 In this type of amyloidosis, 
the heart is involved in 90% of the cases and 50% 
of them present remarkable clinical manifestations. 
The prognosis of these patients is directly associated 
with the presence of cardiac involvement. The overall 
survival time drops from 13 months to 4 months when 
the signs and symptoms of heart failure ensue.2-5
ATTR progresses more slowly than AL amyloidosis, 
and most untreated patients live many years after the 
first signs of the disease.2
Diastolic cardiac failure and conduction system 
disturbances characterize the cardiac involvement. 
The commonest congestive signs are represented by 
dyspnea and edema of lower extremities. Coronary 
artery amyloid deposition may lead to angina or 
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myocardial infarction. The presence of syncope may be 
related to autonomic dysfunction and/or arrhythmias, 
which usually signals a poor prognosis since it may lead 
to sudden death. The amyloid deposition in the cardiac 
conduction system frequently involves the His-Purkinje 
system, while the atrioventricular node function is 
usually spared and preserved.5,6 The predominant valvar 
involvement in amyloidosis is very uncommon.7,8
The clinical diagnosis of cardiac involvement 
in amyloidosis is challenging. Suspicion should be 
raised on the basis of clinical features and non-
invasive examination techniques, like the presence 
of low-voltage QRS complex on ECG and thickening 
of the ventricular wall on echocardiography. Cardiac 
magnetic resonance imaging and the positron emission 
tomography scan are more specific and therefore may 
be useful. The gold standard diagnostic tool is the 
presence of amyloid in endomyocardial or abdominal 
fat biopsy.6
Treatment of cardiac amyloidosis is based on 
the relief of symptoms and, when feasible, in the 
reduction of the amyloid production with the aid of 
chemotherapy or bone marrow transplantation.4,6
CASE REPORT
A 46-year-old male patient sought the emergency 
room complaining of abdominal pain, nausea, 
vomiting, anorexia, drowsiness, and coughing when 
lying down. His past medical history included non-
dialytic chronic renal failure of unknown cause, and 
aortic valve insufficiency. During the last 40 days he 
referred weight loss of 15 kg.
On admission he was pale, dehydrated, and 
icteric; his pulse rate was 100 beats per minutes, and 
his respiratory rate was 16 breaths per minute. The 
cardiac and abdominal examination was unremarkable 
but the pulmonary examination revealed reduced 
breath sounds in the lung bases.
Laboratory work-up showed persistent and 
elevated liver enzymes, bilirubin, prothrombin activity, 
and creatinine as summarized in Table 1. Antinuclear 
antibody, VDRL, hepatitis A, B and C, cytomegalovirus, 
rubella, and toxoplasmosis serologies were negative.
The plain chest radiography (Figure 1) showed a 
reduced costophrenic recess and an enlarged cardiac 
silhouette.
The electrocardiogram showed narrow QRS 
supraventricular tachycardia, low voltage QRS 
complexes in the frontal leads, and electrically inactive 
areas in the inferior and anterior left ventricular walls 
(Figure 2). Abdominal ultrasonography evidenced 
loss of renal corticomedullary differentiation while 
the remaining viscera and the abdominal cavity were 
within normal limits.
The patient outcome was unfavorable with 
decreased mental status and progressive dyspnea 
requiring orotracheal intubation and mechanical 
Table 1. Laboratory analysis during hospitalization
1st day 2nd day 3rd day 4th day 5th day RV
TB 2.9 3.2 3.7 4.5 4.1 0.3-1.2 mg/dL
DB 1.9 2.1 2.5 2.8 2.3 < 0.2 mg/dL
AP 264 244 - - - 90-360 U/L
γGT 116 105 79 - - < 73 U/L
AST 223 218 141 113 53 0-33 U/L
ALT 1562 1452 935 816 380 10-40 U/L
INR 1.45 1.2 1.96 2.21 2.08 1
LDH - - 466 - - 240-480 UI/L
C-RP - - 8.9 8.9 - 1 mg/dL
TP - - - 4.9 4.4 5.7-8.2 g/dL
C 2.7 2.6 2.6 3.0 3.0 0.6-1.3 mg/dL
U 117 101 109 77 20-40 mg/dL
ALT = alanine aminotransferase, AP = alkaline phosphatase, AST = aspartate aminotransferase, C = creatinine, 
C-RP = C-reactive protein, DB = direct bilirubin, γGT = gamma glutamyl transpeptidase, INR = international normalized 
ratio, LDH = lactate dehydrogenase, RV = reference value, TB = total bilirubin, TP = total protein, U = urea.
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ventilatory support. He presented two episodes of 
cardiac arrest ending with unresponsive hypotension 
and death. Because of the impossibility to assure the 
diagnosis during life, an autopsy was undertaken.
AUTOPSY FINDINGS
At ectoscopy, generalized edema was present. At 
the opening of cavities, 1400 mL was drained from the 
right hemithorax, 1200 mL from the left hemithorax, 
50 mL from the pericardial sac, and 1200 mL from the 
peritoneal cavity. All effusions were clear and yellowish. 
The brain weighted 1250g (reference value [RV]: 
1100 g) and presented a slight edema characterized 
by broadening of gyri and sulci effacement. On brain 
microscopy, vascular congestion was observed.
The heart weighted 580 g, (RV: 350 g) and 
presented thickening of ventricular walls measuring 
1,6cm (RV: 1,5cm) (Figure 3A). Ventricular cavities 
were dilated and a mural thrombus was identified in 
the right atrium. The endocardium showed a diffuse 
micro granular surface accompanied by thickening 
and retraction of the aortic valve (Figure 3B and 3D). 
Histologic examination revealed the interstitial 
deposition of amyloid surrounding the cardiomyocytes 
Figure 1. Plain chest radiography showing cardiomegaly and left reduced costophenic recess.
Figure 2. Electrocardiogram showing narrow QRS supraventricular tachycardia, and low voltage QRS complexes on 
frontal leads and anterior left ventricular walls.
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and thickening of the ventricular wall and endocardium 
(Figure 3C).
The right lung weighed 950 g and the left 
640 g (RV: 450 g and 400 g, respectively); both were 
congested. Hemorrhagic infarctions were identified in 
the right lower and middle pulmonary lobes (Figure 4A). 
On histology, besides the findings consistent with 
pulmonary infarction (Figure 4B), alveolar septa 
(Figure 4C and 4D) and vessel walls (Figure 4D) were 
thickened by amyloid deposition. Alveolar edema and 
hemosiderin-laden macrophages (heart failure cells) 
characterized the microscopic findings.
The liver weighed 1680 g (RV: 1400 g) and 
exhibited the classic nutmeg appearance (Figure 5A). 
Hemorrhagic necrosis of the zone 3 and hemosiderin 
were present on histology (Figure 5B). Hepatic 
amyloidosis involvement was restricted to the portal 
vessel wall (Figure 5C).
The spleen weighed 450 g (RV: 200 g) was 
hardened and pale. On microscopy, the amyloid was 
diffusely deposited involving both the white and the 
red pulp (Figure 5D).
The kidneys weighed 150 g each (RV: 200 g) and 
showed a granular external surface (Figure 6A). The 
parenchyma was atrophic with hilar fat replacement 
(Figure 6A). Amyloid deposition was observed in some 
glomeruli, widening the mesangium (Figure 6B) and 
thickening the afferent arteriole accompanied by 
Figure 3. A – Transversal section of the ventricles showing the myocardial thickening associated with the left 
ventricular dilatation; B – Thickened and retracted aortic valve; C – Photomicrography of the myocardium showing 
interstitial deposition of the amyloid substance involving the myocardiocytes (HE – AO = 200X); D – Photomicrography 
of the aortic valve showing amyloid substance deposition (HE – AO = 100X).
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Figure 4. A – Pulmonary hemorrhagic infarct associated with the pulmonary embolus found in the hilum (white 
arrow); B – Photomicrography of the pulmonary vessel showing evidence of the pulmonary embolus with the 
hemorrhagic area of the parenchyma (HE – AO = 50X); C – Photomicrography of the lung showing diffuse thickening 
of the interalveolar septa (HE – AO = 200X); D – Photomicrography of the lung showing diffuse thickening of the 
interalveolar septa (arrowhead) and of the vascular walls (arrow) due to deposition of amyloid substance and the 
presence of macrophages with hemosiderin pigment in the alveolar spaces (HE – AO = 400X).
glomerular atrophy (Figure 6C and 6D). Scattered areas 
of fibrosis and lymphocytic infiltration were observed.
Vascular wall deposition of amyloid was also 
observed in the thyroid, pancreas, and small bowel, 
where hemorrhagic foci were observed. The Congo 
red staining after examination under polarized light 
microscopy confirmed amyloid deposition (Figure 7A 
and 7B).
Signs of infection, chronic inflammatory disease, 
or plasma cell neoplasm were not identified. Bone 
marrow biopsy was not performed.
Immunohistochemical staining was performed for 
serum amyloid A and monoclonal lambda and kappa 
light-chains (ATTR wild-type was not available). The 
reaction was positive for monoclonal lambda light-
chain on vascular walls and interstitial amyloid deposits 
(Figure 7C and 7D).
DISCUSSION
In the present case, the autopsy was fundamental 
to establish the diagnosis. Systemic amyloidosis is 
frequently associated with plasma cell dyscrasia, 
chronic inflammatory disease, chronic infection and 
hemodialysis. The two most common types of amyloid 
that infiltrate the heart are: immunoglobulin light-chain 
(AL or primary systemic) amyloid, and transthyretin 
(TTR) amyloid. AL amyloidosis has a poor prognosis, 
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as in this case, with median survival following 
diagnosis of < 1 year in the presence of heart failure 
symptoms. Unlike AL heart disease, transthyretin-
related amyloid cardiomyopathy is slowly progressive 
and clinically well tolerated, often defying diagnosis 
until marked ventricular wall thickening, profound 
diastolic dysfunction, and conduction disease have 
occurred. Untreated, survival with transthyretin-related 
cardiac amyloidosis is measured in years to decades.9 
Most of the AL-amyloidosis cases are not associated 
with multiple myeloma or other B-cell neoplasia, and 
are traditionally classified as primary amyloidosis.
In the case presented herein, the initial presentation 
was renal failure. The involvement of other organs is 
generally silent and progressive. Cardiac involvement, 
in this form of amyloidosis, shows a restrictive 
pattern with elevated jugular venous pressure, 
ventricular gallop, systemic venous congestion, and 
hepatomegaly.1 The outcome is variable among 
different types of amyloidosis, but the cardiac 
involvement defines the prognosis in all types.10
Cardiac involvement is represented by the 
thickening of all cardiac chamber walls accompanied 
by biatrial dilation, a normal or mildly dilated right 
ventricle, and a normal-to-small left ventricle chamber.10 
In our case, we observed left ventricle dilation, which 
was most probably related to the aortic insufficiency 
that was secondary to the valvar amyloid infiltration.
Figure 5. A – Liver segment showing the classical aspect of “nutmeg liver”; B – Photomicrography of the liver 
showing centrilobular hemorrhagic necrosis associated with the deposition of hemosiderin (arrow) (HE – AO 
= 400X); C – Photomicrography of the liver involvement by amyloidosis restricted to the portal vascular structures 
(arrow) (HE – AO = 100X); D – Photomicrography of the spleen showing the extent involvement of the spleen by 
amyloidosis, both in the red and the white pulps (HE – AO = 400X).
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Pulmonary amyloidosis is rare; however, this 
involvement is more frequently observed in primary AL 
amyloidosis. In these cases, the amyloid is deposited 
in the airways or in the alveolar septa following 
either a diffuse or nodular deposition pattern. In our 
case, the autopsy findings showed parenchymal and 
vascular amyloid deposition in a diffuse pattern, which 
corresponded to the most common pattern of systemic 
amyloidosis.11
The glomerular mesangial expansion is the most 
frequent renal involvement in amyloidosis. In our 
case, we observed the predominance of vascular 
involvement with consequent parenchymal atrophy, 
which is more rare.12,13
Immunohistochemical staining for monoclonal 
lambda light chain was positive in this case. This may 
suggest primary amyloidosis, which may be related to 
some plasma cell dyscrasia. Unfortunately the bone 
marrow was not sampled in this autopsy, but bone 
lesions and systemic signs of plasma cell proliferation 
were absent.
We would like to highlight the marked elevation of 
hepatic enzymes, which were somewhat disproportional 
to the liver parenchyma lesion. We considered that 
the passive hepatic congestion added to the amyloid 
deposition in hepatic vessel walls could lead to 
hepatocytes ischemia and, consequently, an increase 
in hepatic enzymes.14-16 Recently, a study involving 489 
patients diagnosed with heart failure (independently 
of the staging) evidenced elevated determination of 
transaminases in 25% of patients.17 Passive hepatic 
congestion due to increased central venous pressure 
Figure 6. A – Gross appearance of the contracted kidneys, with atrophy and granulous surface; B – Photomicrography 
showing mesangial deposition of amyloid substance (HE – AO = 200X); C and D – Photomicrography of the kidney 
showing (in the great majority of the glomeruli) the evident thickening of the afferent arteriole (C: HE – AO = 400X; 
D: HE – AO = 200X).
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may cause elevations of liver enzymes and both direct 
and indirect serum bilirubin. Impaired perfusion from 
decreased cardiac output may be associated with 
acute hepatocellular necrosis with marked elevations 
in serum aminotransferases.18 This entity was called 
ischemic hepatitis. Cardiogenic ischemic hepatitis 
(“shock liver”) may ensue following an episode of 
profound hypotension in patients with acute heart 
failure. Hepatic dysfunction due to passive congestion 
is particularly common in patients with right-sided 
heart failure with elevated right ventricular pressure, 
which occurs in restrictive cardiomyopathy and was 
seen in this case.
Cardiac amyloidosis diagnosis is difficult, and 
often diagnosed solely at autopsy. Therefore, an early 
diagnosis is fundamental for starting the treatment as 
soon as possible, since it may be the only chance for 
a good prognosis.
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